Ductal carcinoma in situ - The influence of the radiotherapy boost on local control

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages

  Wong, Philip ^a   Lambert, Christine ^a   Agnihotram, Ramanakumar V ^b   David, Marc ^a   Duclos, Marie ^a   Freeman, Carolyn R ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Boost; Breast; Ductal carcinoma in situ; Radiotherapy

Indexed keywords

BOOST; BREAST; BREAST CONSERVING SURGERY; COX REGRESSION ANALYSIS; DUCTAL CARCINOMA IN SITU; FRACTIONATION SCHEDULES; KAPLAN-MEIER; LOCAL CONTROL; LOCAL RECURRENCE; MARGIN STATUS; MCGILL UNIVERSITY; PROGNOSTIC FACTORS; RISK CATEGORIES; SURVIVAL ANALYSIS; TUMOR SIZE; UNIVARIATE ANALYSIS; WHOLE-BREAST IRRADIATION;

HEALTH RISKS; IRRADIATION; REGRESSION ANALYSIS; SURGERY;

RADIOTHERAPY;

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DISEASE SEVERITY; EVALUATION AND FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NECROSIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RECURRENCE RISK; RISK ASSESSMENT; TUMOR VOLUME;

AGE FACTORS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NECROSIS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RADIOTHERAPY, ADJUVANT; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR BURDEN;

EID: 84855829091     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.03.045     Document Type: Article

References (28)

1. Virnig BA, Tuttle TM, Shamliyan T, et al. Ductal carcinoma in situ of the breast: A systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst;102:170-178.
2. B. Fisher, S. Land, and E. Mamounas Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience Semin Oncol 28 2001 400 418
3. N. Bijker, P. Meijnen, and J.L. Peterse Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 - a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group J Clin Oncol 24 2006 3381 3387
4. J. Houghton, W.D. George, and J. Cuzick Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: Randomised controlled trial Lancet 362 2003 95 102
5. S.O. Emdin, B. Granstrand, and A. Ringberg SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening Acta Oncol 45 2006 536 543
6. P. Romestaing, Y. Lehingue, and C. Carrie Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France J Clin Oncol 15 1997 963 968
7. H. Bartelink, J.C. Horiot, and P.M. Poortmans Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-Year results of the randomized boost versus no boost EORTC 22881-10882 trial J Clin Oncol 25 2007 3259 3265
8. A. Omlin, M. Amichetti, and D. Azria Boost radiotherapy in young women with ductal carcinoma in situ: A multicentre, retrospective study of the Rare Cancer Network Lancet Oncol 7 2006 652 656
9. R. Yerushalmi, A. Sulkes, and M. Mishaeli Radiation treatment for ductal carcinoma in situ (DCIS): Is a boost to the tumor bed necessary? Neoplasma 53 2006 507 510
10. N. Bijker, E.J. Rutgers, and J.L. Peterse Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS Eur J Surg Oncol 27 2001 135 140
11. T.B. Julian, S.R. Land, and Y. Wang Is boost therapy necessary in the treatment of DCIS? J Clin Oncol 26 2008 (May 20 suppl; abstr 537)
12. A. Monteau, B. Sigal-Zafrani, and Y.M. Kirova Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: Treatment with reexcision or radiotherapy with increased dosage Int J Radiat Oncol Biol Phys 75 2009 1021 1028
13. D. Azria, H. Auvray, and I. Barillot [Ductal carcinoma in situ: Role of the boost] Cancer Radiother 12 2008 571 576
14. T. Whelan, R. MacKenzie, and J. Julian Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer J Natl Cancer Inst 94 2002 1143 1150
15. M.J. Silverstein An argument against routine use of radiotherapy for ductal carcinoma in situ Oncology (Williston Park) 17 2003 1511 1533 discussion 1533-1514, 1539, 1542 passim
16. M.J. Silverstein The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast Am J Surg 186 2003 337 343
17. G.P. Boland, K.C. Chan, and W.F. Knox Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery Br J Surg 90 2003 426 432
18. B. Cutuli, R. Fay, and C. Cohen-Solal-Le Nir [Ductal carcinoma in situ of the breast. Analysis of 882 cases] Presse Med 33 2004 83 89
19. S.G. MacAusland, J.T. Hepel, and F.K. Chong An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ Cancer 110 2007 2648 2653
20. O. Gilleard, A. Goodman, and M. Cooper The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ World J Surg Oncol 6 2008 61
21. S. Di Saverio, F. Catena, and D. Santini 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: A retrospective review with long term follow up Breast Cancer Res Treat 109 2008 405 416
22. T.J. Whelan, J.P. Pignol, and M.N. Levine Long-term results of hypofractionated radiation therapy for breast cancer N Engl J Med 362 2010 513 520
23. D.N. Poller, M.J. Silverstein, and M. Galea Ideas in pathology. Ductal carcinoma in situ of the breast: A proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression Mod Pathol 7 1994 257 262
24. M.D. Lagios Classification of duct carcinoma in situ (DCIS) with a characterization of high grade lesions: Defining cohorts for chemoprevention trials J Cell Biochem Suppl 25 1996 108 111
25. D.M. Landis, W. Luo, and J. Song Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity Int J Radiat Oncol Biol Phys 67 2007 1299 1308
26. J. Ringash, T. Whelan, and E. Elliott Accuracy of ultrasound in localization of breast boost field Radiother Oncol 72 2004 61 66
27. R.K. Benda, G. Yasuda, and A. Sethi Breast boost: Are we missing the target? Cancer 97 2003 905 909
28. D. Williamson, R. Dinniwell, and S. Fung Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ Radiother Oncol 95 2010 317 320